{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:05:53Z","timestamp":1707523553967},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.7759\/cureus.45091","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T12:06:51Z","timestamp":1694520411000},"source":"Crossref","is-referenced-by-count":0,"title":["Recurrent Multifocal Embolic Strokes in a 50-Year-Old Male: Unmasking Occult Squamous Cell Carcinoma"],"prefix":"10.7759","author":[{"given":"Deipthan","family":"Prabakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishnavi","family":"Sabesan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwasegun  P","family":"Emenogu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuc","family":"Mai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Stroke: etiology, classification, and epidemiology","author":"Caplan LR","year":"2022","unstructured":"Caplan LR, Kasner SE, Dashe JF. Stroke: etiology, classification, and epidemiology. UpToDate. Ted W Post (ed): UpToDate, Waltham, Massachusetts; 2022."},{"key":"ref2","article-title":"Cryptogenic stroke and embolic stroke of undetermined source (ESUS)","author":"Prabhakaran S","year":"2023","unstructured":"Prabhakaran S, Ibeh C, Kasner SE, Dashe JF. Cryptogenic stroke and embolic stroke of undetermined source (ESUS). UpToDate. Ted W Post (ed): UpToDate, Waltham, Massachusetts; 2023."},{"key":"ref3","article-title":"Stroke and cancer- a complicated relationship","volume":"2","author":"Dearborn JL","year":"2014","unstructured":"Dearborn JL, Urrutia VC, Zeiler SR. Stroke and cancer- a complicated relationship. J Neurol Transl Neurosci. 2014, 2:1039.","journal-title":"J Neurol Transl Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s11936-018-0635-x","article-title":"Arterial thrombosis in patients with cancer","volume":"20","author":"Tuzovic M","year":"2018","unstructured":"Tuzovic M, Herrmann J, Iliescu C, Marmagkiolis K, Ziaeian B, Yang EH. Arterial thrombosis in patients with cancer. Curr Treat Options Cardiovasc Med. 2018, 20:40. 10.1007\/s11936-018-0635-x","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000484668","article-title":"When to screen ischaemic stroke patients for cancer","volume":"45","author":"Selvik HA","year":"2018","unstructured":"Selvik HA, Bjerkreim AT, Thomassen L, Waje-Andreassen U, Naess H, Kvistad CE. When to screen ischaemic stroke patients for cancer. Cerebrovasc Dis. 2018, 45:42-7. 10.1159\/000484668","journal-title":"Cerebrovasc Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-218105","article-title":"Multiple recurrent ischaemic strokes in a patient with cancer: is there a role for the initiation of anticoagulation therapy for secondary stroke prevention?","volume":"2017","author":"Suero-Abreu GA","year":"2017","unstructured":"Suero-Abreu GA, Cheng JZ, Then RK. Multiple recurrent ischaemic strokes in a patient with cancer: is there a role for the initiation of anticoagulation therapy for secondary stroke prevention?. BMJ Case Rep. 2017, 2017:bcr-2016-218105. 10.1136\/bcr-2016-218105","journal-title":"BMJ Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000439549","article-title":"DWI lesion patterns in cancer-related stroke - specifying the phenotype","volume":"5","author":"Schwarzbach CJ","year":"2015","unstructured":"Schwarzbach CJ, Fatar M, Eisele P, Ebert AD, Hennerici MG, Szabo K. DWI lesion patterns in cancer-related stroke - specifying the phenotype. Cerebrovasc Dis Extra. 2015, 5:139-45. 10.1159\/000439549","journal-title":"Cerebrovasc Dis Extra"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau's syndrome: multiple definitions and multiple mechanisms","volume":"110","author":"Varki A","year":"2007","unstructured":"Varki A. Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood. 2007, 110:1723-9. 10.1182\/blood-2006-10-053736","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900263","article-title":"The hypercoagulable state of malignancy: pathogenesis and current debate","volume":"4","author":"Caine GJ","year":"2002","unstructured":"Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002, 4:465-73. 10.1038\/sj.neo.7900263","journal-title":"Neoplasia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044959","article-title":"Clues to occult cancer in patients with ischemic stroke","volume":"7","author":"Kim SJ","year":"2012","unstructured":"Kim SJ, Park JH, Lee MJ, Park YG, Ahn MJ, Bang OY. Clues to occult cancer in patients with ischemic stroke. PLoS One. 2012, 7:e44959. 10.1371\/journal.pone.0044959","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4669","article-title":"Cancer-associated stroke: pathophysiology, detection and management (Review)","volume":"54","author":"Dardiotis E","year":"2019","unstructured":"Dardiotis E, Aloizou AM, Markoula S, et al.. Cancer-associated stroke: pathophysiology, detection and management (Review). Int J Oncol. 2019, 54:779-96. 10.3892\/ijo.2019.4669","journal-title":"Int J Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/tcmj.tcmj_55_19","article-title":"Anticoagulants for cancer-associated ischemic stroke","volume":"31","author":"Hsu JY","year":"2019","unstructured":"Hsu JY, Liu AB. Anticoagulants for cancer-associated ischemic stroke. Ci Ji Yi Xue Za Zhi. 2019, 31:144-8. 10.4103\/tcmj.tcmj_55_19","journal-title":"Ci Ji Yi Xue Za Zhi"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.022","article-title":"Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study","volume":"23","author":"Guo YJ","year":"2014","unstructured":"Guo YJ, Chang MH, Chen PL, Lee YS, Chang YC, Liao YC. Predictive value of plasma (D)-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovasc Dis. 2014, 23:e249-54. 10.1016\/j.jstrokecerebrovasdis.2013.10.022","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.7351","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical clinical practice guideline update 2014","volume":"33","author":"Lyman GH","year":"2015","unstructured":"Lyman GH, Bohlke K, Khorana AA, et al.. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology Clinical clinical practice guideline update 2014. J Clin Oncol. 2015, 33:654-6. 10.1200\/JCO.2014.59.7351","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/17562864221106362","article-title":"Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach","volume":"15","author":"Woock M","year":"2022","unstructured":"Woock M, Martinez-Majander N, Seiffge DJ, et al.. Cancer and stroke: commonly encountered by clinicians, but little evidence to guide clinical approach. Ther Adv Neurol Disord. 2022, 15:17562864221106362. 10.1177\/17562864221106362","journal-title":"Ther Adv Neurol Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5133","article-title":"Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis","volume":"347","author":"Castellucci LA","year":"2013","unstructured":"Castellucci LA, Cameron C, Le Gal G, et al.. Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis. BMJ. 2013, 347:f5133. 10.1136\/bmj.f5133","journal-title":"BMJ"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht049","article-title":"New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis","volume":"34","author":"Oldgren J","year":"2013","unstructured":"Oldgren J, Wallentin L, Alexander JH, James S, J\u00f6nelid B, Steg G, Sundstr\u00f6m J. New oral anticoagulants in addition to single or dual antiplatelet therapy after an acute coronary syndrome: a systematic review and meta-analysis. Eur Heart J. 2013, 34:1670-80. 10.1093\/eurheartj\/eht049","journal-title":"Eur Heart J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013267","article-title":"Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Systematic review and meta-analysis","volume":"132","author":"Sharma M","year":"2015","unstructured":"Sharma M, Cornelius VR, Patel JP, Davies JG, Molokhia M. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism. Systematic review and meta-analysis. Circulation. 2015, 132:194-204. 10.1161\/CIRCULATIONAHA.114.013267","journal-title":"Circulation"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2738","article-title":"Cancer-related stroke: exploring personalized therapy strategies","volume":"12","author":"Chen YJ","year":"2022","unstructured":"Chen YJ, Dong RG, Zhang MM, Sheng C, Guo PF, Sun J. Cancer-related stroke: exploring personalized therapy strategies. Brain Behav. 2022, 12:e2738. 10.1002\/brb3.2738","journal-title":"Brain Behav"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02903.x","article-title":"Cryptogenic stroke: time to determine aetiology","volume":"6","author":"Guercini F","year":"2008","unstructured":"Guercini F, Acciarresi M, Agnelli G, Paciaroni M. Cryptogenic stroke: time to determine aetiology. J Thromb Haemost. 2008, 6:549-54. 10.1111\/j.1538-7836.2008.02903.x","journal-title":"J Thromb Haemost"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/187753-recurrent-multifocal-embolic-strokes-in-a-50-year-old-male-unmasking-occult-squamous-cell-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:49:08Z","timestamp":1707508148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/187753-recurrent-multifocal-embolic-strokes-in-a-50-year-old-male-unmasking-occult-squamous-cell-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.45091","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}